ArticleCost effectiveness and resource allocation : C/E2021

Cost-effectiveness analysis of neoadjuvant versus adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer patients during initial treatment phase.

Dongdong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.